NASDAQ:DXCM Stock Quote
Dexcom Inc is a leading company specializing in continuous glucose monitoring systems for individuals with diabetes
Their innovative technology enables users to track glucose levels in real time through a small sensor placed under the skin, eliminating the need for traditional fingerstick testing. The company's products empower patients and healthcare providers to make informed decisions regarding diabetes management, enhancing the quality of life for those living with the condition. By integrating advanced software and mobile applications, Dexcom's systems deliver essential insights and alerts, contributing to better health outcomes for users.
Frequently Asked Questions
Can DexCom CGM be used with insulin pumps?
Yes, DexCom CGM systems can be integrated with various insulin pumps to provide users with a comprehensive diabetes management solution. This integration allows for real-time data sharing, enabling better decision-making regarding insulin dosing.
Does DexCom offer its products internationally?
Yes, DexCom offers its products internationally. The company has expanded its reach to various countries across Europe, Asia, and other regions, catering to the global demand for effective diabetes management solutions.
How can customers obtain DexCom products?
Customers can obtain DexCom products through healthcare providers, pharmacies, and online ordering through their official website or authorized distributors. It's important for users to consult their healthcare providers to ensure they receive the appropriate products for their needs.
How does DexCom handle data security?
DexCom is committed to data security and employs industry-standard measures to safeguard users' personal information and health data. They follow stringent privacy policies to ensure that data is protected and used appropriately in accordance with regulations.
How does DexCom support diabetes management?
DexCom supports diabetes management through educational resources, online tools, and partnerships with healthcare providers to ensure users have the necessary information and support to use their CGM effectively and incorporate it into their daily routines.
How does the DexCom CGM system work?
The DexCom CGM system works by using a small sensor inserted under the skin to measure glucose levels in interstitial fluid. It transmits this data to a receiver or compatible mobile device every few minutes, allowing users to monitor their glucose trends in real time.
How often should you replace the DexCom sensor?
DexCom sensors are typically designed to be worn for up to 10 days before replacement. After this period, it's important to replace the sensor to ensure accurate glucose readings and maintain proper function of the CGM system.
Is DexCom publicly traded?
Yes, DexCom is publicly traded on the Nasdaq stock exchange under the ticker symbol DXCM. The company has experienced significant growth and has become one of the leading players in the diabetes care market.
What are the benefits of using DexCom CGM?
The benefits of using DexCom's CGM include real-time glucose monitoring, the ability to track trends over time, customizable alerts for high and low glucose levels, and improved data sharing capabilities with healthcare providers, leading to better overall diabetes management.
What does DexCom, Inc. do?
DexCom, Inc. is a medical device company specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. Their products help patients track their glucose levels in real-time, allowing for better management of their condition and reducing the risk of complications associated with diabetes.
What insurance plans cover DexCom products?
Many insurance plans cover DexCom products, but coverage can vary. Patients are encouraged to check with their specific insurance provider to understand the details of their coverage and any out-of-pocket costs associated with DexCom CGM systems.
What is the accuracy of DexCom CGM systems?
DexCom CGM systems are designed to provide highly accurate glucose readings, with clinical studies showing that they achieve high levels of accuracy compared to traditional fingerstick blood tests. This accuracy allows users to make informed decisions regarding their diabetes management.
What is the DexCom G7?
The DexCom G7 is the next generation of DexCom's continuous glucose monitoring systems, featuring a smaller, all-in-one design that simplifies the user experience. It aims to enhance accuracy and ease of use while providing users with similar real-time glucose monitoring capabilities as its predecessor.
What is the DexCom Share feature?
The DexCom Share feature allows users to share their glucose data with friends, family, and healthcare providers in real-time. This enhances support networks and enables caregivers to monitor glucose levels remotely, fostering better management of diabetes.
What is the mission of DexCom?
DexCom's mission is to empower people with diabetes by providing innovative continuous glucose monitoring solutions that improve health outcomes and quality of life. The company is dedicated to advancing diabetes care through technology and education.
What is the role of DexCom in diabetes research?
DexCom plays a vital role in diabetes research by contributing data and technology that aid in clinical studies and collaborations with researchers aimed at improving diabetes management techniques and developing new therapies for diabetes patients.
What products does DexCom offer?
DexCom offers several products, including the Dexcom G6 CGM System, which provides real-time glucose readings, alerts for high and low glucose levels, and an easy-to-use mobile app for data management. They also continually work on new products and enhancements to improve diabetes management.
When was DexCom founded?
DexCom was founded in 1999. The company was established with the vision of providing innovative solutions for diabetes management and has since evolved significantly, pioneering advancements in continuous glucose monitoring technology.
Where is DexCom headquartered?
DexCom is headquartered in San Diego, California. This location allows the company to leverage the rich network of biotech and medical device innovation in the region, contributing to its growth and development.
Who are the primary customers of DexCom?
The primary customers of DexCom are individuals with diabetes, including both type 1 and type 2 diabetes patients, as well as healthcare professionals who prescribe and support CGM systems as part of diabetes management.
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 68.20
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 1:36 pm EDT on April 2nd, 2025
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 26.65B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 390.70M shares outstanding.